HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Read responses to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Henningfield, J E Articles by Zeller, M Search for Related Content PubMed PubMed Citation Articles by Henningfield, J E Articles by Zeller, M Related Collections Tobacco use Health effects of tobacco use

Reducing tobacco addiction through tobacco product regulation

¹ Pinney Associates Inc, Bethesda, Maryland, USA and Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
² University of California San Francisco, San Francisco, California, USA
³ Harvard University School of Public Health, Boston, Massachusetts, USA
⁴ Henry Ford Health System, Detroit, Michigan, USA
⁵ International Agency for Research on Cancer, Lyon, France
⁶ Campaign for Tobacco-Free Kids, Washington, DC, USA
⁷ Pinney Associates, Inc, Bethesda, Maryland, USA

Correspondence to:
Jack E Henningfield PhD
Pinney Associates, Inc, 4800 Montgomery Lane, Suite 1000, Bethesda, MD 20814, USA; jhenning{at}pinneyassociates.com

ABSTRACT
Tobacco product regulation has the potential to help reduce tobacco attributable disease by reducing the toxicity of these products and by reducing the prevalence of tobacco use and addiction

Abbreviations: FCTC, Framework Convention on Tobacco Control; FDA, Food and Drug Administration; FTC, Federal Trade Commission; ISO, International Organization for Standardization

Keywords: addiction; harm reduction; ingredient; regulation

This article has been cited by other articles:

				C. E. Koop Health and Health Care for the 21st Century: For All the People Oncologist, April 1, 2007; 12(4): 366 - 369. [Full Text] [PDF]

				C. E. Koop Health and Health Care for the 21st Century: For All the People Am J Public Health, December 1, 2006; 96(12): 2090 - 2092. [Full Text] [PDF]

				J. E Henningfield, C. A Rose, and M. Zeller Tobacco industry litigation position on addiction: continued dependence on past views Tob. Control, December 1, 2006; 15(suppl_4): iv27 - iv36. [Abstract] [Full Text] [PDF]

				M. J. Pletcher, B. J. Hulley, T. Houston, C. I. Kiefe, N. Benowitz, and S. Sidney Menthol Cigarettes, Smoking Cessation, Atherosclerosis, and Pulmonary Function: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arch Intern Med, September 25, 2006; 166(17): 1915 - 1922. [Abstract] [Full Text] [PDF]

				G Ferris Wayne, G N Connolly, and J E Henningfield Brand differences of free-base nicotine delivery in cigarette smoke: the view of the tobacco industry documents Tob. Control, June 1, 2006; 15(3): 189 - 198. [Abstract] [Full Text] [PDF]

				M. J. Lewis and O. Wackowski Dealing With an Innovative Industry: A Look at Flavored Cigarettes Promoted by Mainstream Brands Am J Public Health, February 1, 2006; 96(2): 244 - 251. [Abstract] [Full Text] [PDF]

				N Gray, J E Henningfield, N L Benowitz, G N Connolly, C Dresler, K Fagerstrom, M J Jarvis, and P Boyle Toward a comprehensive long term nicotine policy Tob. Control, June 1, 2005; 14(3): 161 - 165. [Abstract] [Full Text] [PDF]

				P. J. Mazzone and A. C. Arroliga How Many Ways Can We Say That Cigarette Smoking Is Bad for You? Chest, December 1, 2004; 126(6): 1717 - 1718. [Full Text] [PDF]

eLetters: